ASSOCIATION BETWEEN ABDOMINAL OBESITY, C-PEPTIDE LEVELS, AND INSULIN RESISTANCE IN YOUNG ADULTS
Abstract
Currently, considerable attention is being paid to the concept that abdominal obesity (AO) induces a chronic low-grade systemic inflammatory response, which develops as a result of increased insulin resistance and enhanced production of inflammatory mediators due to the expansion of the adipocyte pool [1, 2]. Visceral adipose tissue is considered a key link between the development of metabolic disturbances and cardiovascular pathology. Given the high global prevalence of AO, including among young individuals [3], this factor has become one of the leading contributors to the development of comorbid conditions. A number of studies have demonstrated that adipokine imbalance is strongly associated with an increased risk of cardiometabolic diseases and their complications [4–6]. In our previous studies, we demonstrated associations between circulating adipokine levels and coronary artery disease (CAD) [7], arterial hypertension (AH) [7], as well as hypercholesterolemia. However, the contribution of adipokines to the development of comorbid conditions remains insufficiently understood. In light of the above, the aim of the present study was to investigate the characteristics of the circulating adipokine profile in young adults with comorbid pathology.
Keywords
young people, comorbid pathology, abdominal obesity, interleukin-6, C-peptide.
References
- Borodkina D.A., Gruzdeva O.V., Belik E.V., Dyleva Yu.A., Palicheva E.I. Perivascular adipose tissue and atherosclerosis: phenotypic features and therapeutic potential. Ateroscleroz, 2020; 16 (2): 63–72. (In Russ.)]. doi: 10.15372/ATER20200206
- Chait A., den Hartigh L.J. Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease. Front. Cardiovasc. Med., 2020; 7: 22. doi: 10.3389/fcvm.2020.00022
- Chan J.L., Stoyneva V., Kelesidis T., Raciti P., Mantzoros C.S. Peptide YY levels are decreased by fasting and elevated following caloric intake but are not regulated by leptin. Diabetologia, 2006; 49: 169– 173. doi: 10.1007/s00125-005-0041-2
- Karra, E.; Chandarana, K.; Batterham, R.L. The role of peptide YY in appetite regulation and obesity. J. Physiol. 2009, 587, 19–25
- Polonskaya Yа.V., Kashtanova E.V., Stakhneva E.M., Shramko V.S., Sadovski E.V., Shcherbakova L.V., Khudyakova A.D., Ragino Yu.I. The level of adipokines in young people with hypertension and abdominal obesity. Arterial Hypertension, 2023; 29 (1): 51–57. (In Russ.)]. doi: 10.18705/1607- 419X-2022-28-6-51-57
- Rizvi I.A., Robinson K., McFadden D.W., Riggs D.R., Jackson B.J, Vona-Davis L. Peptide YY reverses TNF-alpha induced transcription factor binding of interferon regulatory factor-1 and p53 in pancreatic acinar cells. J. Surg. Res., 2006; 136 (1): 25–30. doi: 10.1016/j.jss.2006.05.028
- Ullrich S.S., Otto B., Hutchison A.T., LuscombeMarsh N.D., Horowitz M., Feinle-Bisset C. Comparative effects of intraduodenal protein and lipid on ghrelin, peptide YY, and leptin release in healthy men. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2015; 308 (4): R300–R304. doi: 10.1152/ ajpregu.00504.2014